Wednesday, January 21, 2009

Diversified Abbott Outshines Diversified Johnson & Johnson

Abbott's results were helped by the Xience stent, while J&J's profits fell amid recessionary pressures and generic competition.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)